Touchlight, a Contract Development and Manufacturing Organisation (CDMO), has announced that its Hampton, UK facility has achieved GMP certification. This makes Touchlight the first synthetic DNA manufacturer in the world to receive regulatory approval for the manufacture of Active Pharmaceutical Ingredient (API). This places the company in a unique position to support its growing customer base in...
Leadership change in Europe: Effective February 1, 2025, Dr. Yun Chen will take over the leadership of European production for Covestro's Performance Materials (PM) Business Entity. In this position, he succeeds Dr. Daniel Koch, who is leaving the company at the end of January at his own request. After three successful years as head of Performance Materials Operations APAC, Dr. Yun Chen will...
The Polymers Center in Charlotte, North Carolina, now provides an exceptional opportunity for international companies in the plastics industry to showcase and test their technologies and products in the U.S. market. Through a specially designed "Nesting" program, foreign manufacturers can present their equipment in a state-of-the-art facility spanning approximately 130,000 square feet and benefit...
Bosch is selling the security and communication technology product business of its Building Technologies division to the European private equity firm Triton. The transaction includes the three product areas of video systems, access control and intrusion alarm systems, and communication systems. This corresponds to the entire Bosch Building Technologies product business that is available for sale...
The software company PTC announced that it has partnered with Microsoft and Volkswagen Group to develop a generative artificial intelligence copilot based on the PTC Codebeamer application lifecycle management solution. Codebeamer Copilot will support software development in physical products by enabling software engineers to create and manage product requirements more efficiently as well as test...
Clariant has completed the transition to an additive portfolio that is completely free of per- and polyfluoroalkyl substances (PFAS). This underscores the chemical company's commitment to more sustainable and customer-oriented product development. The transition to PFAS-free additives reflects the company's deep understanding of its customers' needs and its ongoing commitment to environmental...
Roche plans to acquire the biopharmaceutical company Poseida Therapeutics to expand its offering in the fields of oncology, immunology and neurology. The Basel-based pharmaceutical company is investing around $1 billion, or approximately €950 million, in the acquisition. The transaction is expected to be completed in the first quarter of 2025. Poseida Therapeutics specializes in CAR-T cell...
Formnext 2024 took place in Frankfurt/Main in Germany from November 19 to 22, 2024. With numerous world premieres and groundbreaking innovations, the trade fair provided decisive impetus for the future development of industrial production towards greater efficiency, productivity and sustainability. At the trade fair for additive manufacturing, the expansion of application areas as well as faster...
Vetter, a global pharmaceutical service provider, is expanding its management team. From January 2025, Thomas Otto and Peter Sölkner will join Henryk Badack, Titus Ottinger and Carsten Press in managing the family-owned company. By expanding its management team, the independent CDMO for the manufacturing of complex injectable drugs is ensuring its sustainable growth. “We at Vetter are committed to...
The site operator Infrareal wants to take over Takeda's pharmaceutical and biotech site in Orth near Vienna in Lower Austria. The two companies have signed a purchase agreement to this effect. The group is taking over the 24-hectare property from Takeda, including buildings, infrastructure and some pharmaceutical production facilities. The transaction is still subject to the fulfillment of the...
